Insider · CIK 0001838204
Viviane Monges
Files at ADCT (ADC Therapeutics SA), PHVS (Pharvaris N.V.). First filing Sep 25, 2026, latest Sep 25, 2026.
Viviane Monges files SEC Form 4 as director at PHVS (Pharvaris N.V.), and also at ADCT (ADC Therapeutics SA). Since Sep 25, 2026, Viviane Monges has reported 0 open-market buys worth $0 and 1 open-market sell worth $396k, the latest filed on Sep 25, 2026.
A track record needs three past buys with six months of prices behind them; Viviane Monges has 0, so none is measured yet.
The newest scored trade: sold $396k of PHVS on Sep 23, 2026, filed Sep 25, 2026, scored 51 (moderate). In the last 12 months: 0 buys worth $0 and 1 sell worth $396k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
PHVS: Pharvaris N.V.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 51Moderate | Pharvaris N.V. | $396k 11,969 shares | -69% | - |
Transactions
Every row this insider has filed, 7 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 23, 2026 | PHVS Pharvaris N.V. | MOption exercise Common Stock | +11,969 | $8.05 | $96k | 17,469 | 18 d ago |
| Sep 23, 2026 | PHVS Pharvaris N.V. | SOpen-market sale Common Stock | -11,969 | $33.05 | $396k | 5,500 | 18 d ago |
| Sep 23, 2026 | PHVS Pharvaris N.V. | MOption exercise Stock Option (Right to Buy)derivative | -11,969 | $0.00 | $0 | 9,031 | 18 d ago |
| Jun 1, 2026 | ADCT ADC Therapeutics SA | AGrant or award Common Shares | +45,000 | $0.00 | $0 | 189,043 | Jun 3, 2026 |
| Jun 3, 2026 | ADCT ADC Therapeutics SA | FTax withholding Common Shares | -2,596 | $3.08 | $7,996 | 186,447 | Jun 3, 2026 |
| Jun 13, 2025 | ADCT ADC Therapeutics SA | FTax withholding Common Shares | -2,584 | $3.58 | $9,251 | 144,043 | Jun 17, 2025 |
| Jun 3, 2025 | ADCT ADC Therapeutics SA | AGrant or award Common Shares | +40,000 | $0.00 | $0 | 146,627 | Jun 5, 2025 |
Questions about Viviane Monges
Answered from the filings on this page, as of the latest one.
Is Viviane Monges buying or selling?
In the last 12 months Viviane Monges reported 0 open-market buys worth $0 and 1 open-market sell worth $396k on SEC Form 4; the latest was sold $396k of PHVS on Sep 23, 2026. Grants, option exercises and tax withholding are not counted.
How did Viviane Monges's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Viviane Monges has 0.
Where does Viviane Monges file Form 4?
Viviane Monges has filed Form 4 at PHVS (Pharvaris N.V.); ADCT (ADC Therapeutics SA). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.